首页|替格瑞洛与氯吡格雷分别联合阿司匹林治疗冠心病不稳定型心绞痛的疗效比较

替格瑞洛与氯吡格雷分别联合阿司匹林治疗冠心病不稳定型心绞痛的疗效比较

扫码查看
目的 探讨替格瑞洛与氯吡格雷分别联合阿司匹林治疗冠状动脉粥样硬化性心脏病(简称冠心病)不稳定型心绞痛的效果差异.方法 方便选取2019年6月—2022年6月苏州市吴中人民医院收治的102例冠心病不稳定型心绞痛患者为研究对象,以不同治疗方法分为两组.对照组(n=50)行氯吡格雷与阿司匹林联合治疗,观察组(n=52)行替格瑞洛与阿司匹林联合治疗,比较两组的疗效.结果 观察组总疗效率较对照组的高(96.15%vs 80.00%),差异有统计学意义(χ2=6.408,P<0.05).治疗后患者心绞痛发作次数较治疗前少,每次发作持续时间较治疗前短,且观察组较对照组发作次数更少、持续时间更短,差异有统计学意义(P均<0.05).治疗后患者血清超敏C反应蛋白(High Sensitivity C-reactive Protein,hs-CRP)、肿瘤坏死因子-α(Tu-mor Necrosis Factor-α,TNF-α)、白细胞介素-6(Interleukin-6,IL-6)水平较治疗前降低,且观察组各因子水平均低于对照组,差异有统计学意义(P均<0.05).观察组心血管不良反应发生率低于对照组,差异有统计学意义(P<0.05);而观察组出血率与对照组相比,差异无统计学意义(P>0.05).结论 对冠心病不稳定型心绞痛患者,在阿司匹林治疗基础上联合替格瑞洛较氯吡格雷的疗效更为可靠,更利于患者心绞痛症状与炎症反应的改善,能降低患者心血管不良反应发生率,且不增加出血风险.
Comparison of the Efficacy of Tegretol and Clopidogrel Combined with Aspirin respectively in the Treatment of Unstable Angina in Coronary Heart Disease
Objective To explore the differences in the effects of tegretol and clopidogrel combined with aspirin in the treatment of unstable angina in coronary atherosclerotic heart disease(coronary heart disease),respectively.Methods 102 patients with coronary heart disease unstable angina admitted to Suzhou Wuzhong People's Hospital from June 2019 to June 2022 were conveniently selected as the study objects and divided into groups by the difference in treat-ment methods.Control group(n=50)was carried out clopidogrel and aspirin combined treatment,and observation group(n=52)was carried out tegretol and aspirin combined treatment.The efficacy of the two groups was compared.Results The total efficacy rate of the observation group was higher than that of the control group(96.15%vs 80.00%),and the difference was statistically significant(χ2=6.408,P<0.05).The number of angina episodes in patients after treatment was less and the duration of each episode was shorter than before treatment,and the number of episodes and the duration of each episode were less and shorter in the observation group,and the differences were statistically sig-nificant(all P<0.05).The levels of high-sensitivity C-reactive protein(hs-CRP),tumor necrosis factor-α(TNF-α),and interleukin-6(IL-6)were lower in patients after treatment than before treatment,and the levels of each factor in the observation group were lower than those in the control group,and the differences were statistically significant(all P<0.05).The incidence of cardiovascular adverse reactions in the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05).However,there was no statistically significant differ-ence in bleeding rate between the observation group and the control group(P>0.05).Conclusion For patients with un-stable angina in coronary artery disease,the efficacy of combining Tegretol with aspirin therapy is more reliable than that of clopidogrel,which is more conducive to the improvement of angina symptoms and inflammatory response of pa-tients,and reduces the incidence of cardiovascular adverse reactions without increasing the risk of hemorrhage.

TegretolClopidogrelAspirinCoronary heart diseaseUnstable anginaEfficacy

董珍珍、孙中奇、徐寒锡

展开 >

苏州市吴中人民医院心内科,江苏苏州 215128

替格瑞洛 氯吡格雷 阿司匹林 冠心病 不稳定型心绞痛 疗效

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(4)
  • 17